Plum-Set IV Administration Sets 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Hospira Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-09-03
  • 사례 출판 날짜
    2013-09-03
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: hospira plum-set iv administration sets the medicines and healthcare products regulatory agency (mhra), united kingdom (uk) posted a medical device safety alert concerning plum-set iv administration sets for infusion pump and intravenous & blood transfusion, manufactured by hospira inc. all lots manufactured after july 2007 are affected. hospira has received reports, including one that resulted in a serious injury, of fluid leaking at the clave secondary port of hospira plum-set iv administration sets during infusion due to the breaking of the bond between the clave and the secondary port of the plum cassettes. the breaking of the bond can manifest itself as either cracking of the bond between the clave and the secondary port or the complete separation of the clave from the secondary port. breakage of the connection or leaking of fluid may result in a delay of therapy and subsequently lead to death or permanent injury if the therapy is life-sustaining. moreover, leakage of a caustic substance such as an oncolytic can result in short term harms such as pain or chemical burns, or long term harm such as tissue necrosis. in order to minimize the possibility of separation or breakage of the clave directly bonded to the secondary port of the plum cassette, hospira recommends users to follow the instructions below: do not twist or bend the clave when accessing the secondary port. ensure all instructions for use are completely followed. ensure local protocol for administering fluids and blood products are completely followed. in addition, hospira will update the instructions for use of the device to reflect the above recommendations and will also be working to determine a different method by which the clave can be bonded to the secondary port of plum cassettes. for details, please visit the following mhra website: http://www.Mhra.Gov.Uk/safetyinformation/safetywarningsalertsandrecalls/fieldsafetynotices/con309602 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 3 september 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Hospira Plum-Set IV Administration Sets
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH